| Daniel R Kloster, M D | |
|
5701 W 119th St Ste 102, Overland Park, KS 66209 | |
| (913) 498-6124 | |
| (913) 498-6117 |
| Full Name | Daniel R Kloster |
|---|---|
| Gender | Male |
| Speciality | Interventional Pain Management |
| Experience | 31 Years |
| Location | 5701 W 119th St Ste 102, Overland Park, Kansas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1346237088 | NPI | - | NPPES |
| 208858621 | Medicaid | MO | |
| 7905560001 | Other | KS | DME |
| 073057 | Other | MO | FHP MEDICAID |
| 26073028 | Other | MO | BCBS OF KANSAS CITY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208VP0000X | Pain Medicine - Pain Medicine | 118941 (Missouri) | Secondary |
| 208VP0014X | Pain Medicine - Interventional Pain Medicine | 118941 (Missouri) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Menorah Medical Center | Overland park, KS | Hospital |
| Kansas City Orthopaedic Institute | Leawood, KS | Hospital |
| Adventhealth Shawnee Mission | Shawnee mission, KS | Hospital |
| University Of Kansas Hospital | Kansas city, KS | Hospital |
| St Joseph Medical Center | Kansas city, MO | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Crimson Pain Management, Llc | 4880831726 | 2 |
| Select Physical Therapy Holdings Inc | 9537076401 | 1487 |
News Archive
Myriad Genetics, Inc., a leader in molecular diagnostics and personalized medicine, today announced that two important studies will be featured in podium presentations at the 36th annual conference of the National Society of Genetic Counselors in Columbus, OH.
Some adults see their mothers and fathers as still influencing their own health - but in very different ways, according to a new study.
Application of sun protection factor 30 (SPF30) sunscreen prior to exposure to ultraviolet-B (UVB) light delayed melanoma onset in a mouse model of the disease, according to data from a team at The Ohio State University Comprehensive Cancer Center Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute. This data suggest that the mouse model can be used to identify new, more effective melanoma-preventing agents, according to principal investigator Christin Burd, PhD.
Forest Laboratories, Inc. announced today that Teflaro(ceftaroline fosamil), a broad-spectrum bactericidal cephalosporin with activity against both gram-positive and gram-negative microorganisms, was approved by the U.S. Food and Drug Administration (FDA) for the treatment of community-acquired bacterial pneumonia (CABP), including cases caused by Streptococcus pneumoniae bacteremia, and acute bacterial skin and skin structure infection (ABSSSI), including cases caused by methicillin-resistant Staphylococcus aureus (MRSA).
› Verified 8 days ago
| Entity Name | Crimson Pain Management, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1740528637 PECOS PAC ID: 4880831726 Enrollment ID: O20130517000558 |
News Archive
Myriad Genetics, Inc., a leader in molecular diagnostics and personalized medicine, today announced that two important studies will be featured in podium presentations at the 36th annual conference of the National Society of Genetic Counselors in Columbus, OH.
Some adults see their mothers and fathers as still influencing their own health - but in very different ways, according to a new study.
Application of sun protection factor 30 (SPF30) sunscreen prior to exposure to ultraviolet-B (UVB) light delayed melanoma onset in a mouse model of the disease, according to data from a team at The Ohio State University Comprehensive Cancer Center Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute. This data suggest that the mouse model can be used to identify new, more effective melanoma-preventing agents, according to principal investigator Christin Burd, PhD.
Forest Laboratories, Inc. announced today that Teflaro(ceftaroline fosamil), a broad-spectrum bactericidal cephalosporin with activity against both gram-positive and gram-negative microorganisms, was approved by the U.S. Food and Drug Administration (FDA) for the treatment of community-acquired bacterial pneumonia (CABP), including cases caused by Streptococcus pneumoniae bacteremia, and acute bacterial skin and skin structure infection (ABSSSI), including cases caused by methicillin-resistant Staphylococcus aureus (MRSA).
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Daniel R Kloster, M D 7100 College Blvd, Overland Park, KS 66210-1862 Ph: (913) 242-7570 | Daniel R Kloster, M D 5701 W 119th St Ste 102, Overland Park, KS 66209 Ph: (913) 498-6124 |
News Archive
Myriad Genetics, Inc., a leader in molecular diagnostics and personalized medicine, today announced that two important studies will be featured in podium presentations at the 36th annual conference of the National Society of Genetic Counselors in Columbus, OH.
Some adults see their mothers and fathers as still influencing their own health - but in very different ways, according to a new study.
Application of sun protection factor 30 (SPF30) sunscreen prior to exposure to ultraviolet-B (UVB) light delayed melanoma onset in a mouse model of the disease, according to data from a team at The Ohio State University Comprehensive Cancer Center Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute. This data suggest that the mouse model can be used to identify new, more effective melanoma-preventing agents, according to principal investigator Christin Burd, PhD.
Forest Laboratories, Inc. announced today that Teflaro(ceftaroline fosamil), a broad-spectrum bactericidal cephalosporin with activity against both gram-positive and gram-negative microorganisms, was approved by the U.S. Food and Drug Administration (FDA) for the treatment of community-acquired bacterial pneumonia (CABP), including cases caused by Streptococcus pneumoniae bacteremia, and acute bacterial skin and skin structure infection (ABSSSI), including cases caused by methicillin-resistant Staphylococcus aureus (MRSA).
› Verified 8 days ago
Dr. Matthew Eric Nadler, M.D. Pain Medicine Medicare: Accepting Medicare Assignments Practice Location: 8101 W 135th St, Suite 200, Overland Park, KS 66223 Phone: 913-491-3999 Fax: 913-491-9309 |